I have been asked by others as to whether I know
I have been asked by others as to whether I know IPIX/Brilacidin was on the agenda today and of course I said no.
I then gave my reasoning as to why I feel it was on the agenda to include the makeup of the panel, the strength of the data and the fact that it was derived from the INH's own RBLs, the PAN-CORONA request showing a far greater potential use for B than just CV19, the 3-in-1 and immunomodulatory properties, multiple MOAs to kill/stop replication of the virus, etc.
IMO it is like a sports team evaluating draft choices - they start with the #1 pick and work down and from what we have seen to date, Brilacidin dwarfs all other drugs that have been trotted out as possible answers to the CV19 problem.
I also said if it wasn't on the agenda and this is the agency that IPIX/RBL submitted their request, that someone should be brought up on criminal charges for derilection of duty.
3
Innovation Pharmaceuticals Inc (IPIX) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Understanding Investor Sentiment for Dell Technologies Dell Technologies's recent report provides insight into the company's short interest metrics, illustrating a decline of 14.71%. Currently, 17.41 million shares are sold short, which represents about 5.8% of the company's available shares for trading. With an average trading volume indicating it would take 2.78 days to...
Continue Reading
Compass Diversified Investigates Securities Fraud Claims Compass Diversified (NYSE: CODI) is currently facing serious allegations relating to violations in securities laws. An investigation has been initiated to determine the validity of these claims and how they may affect investors. This situation has raised alarms in the investment community as stakeholders seek...
Continue Reading
Understanding the Dow Inc. Class Action Lawsuit Opportunities Investors in Dow Inc. (NYSE: DOW) have a significant opportunity to take action due to a recent class action lawsuit against the company. This legal movement stems from allegations regarding Dow's disclosure practices and possible financial mismanagement. People who purchased or acquired securities within a...
Continue Reading
Overview of the Medical Imaging Reagents Market The medical imaging reagents market is on the verge of significant growth, projected to reach USD 19.31 billion by 2034. This growth, at a compound annual growth rate (CAGR) of 5.1%, reflects the increasing importance of imaging technologies in healthcare. Key Drivers of Market Growth Several factors are driving this...
Continue Reading
GBank Financial Holdings Inc. Welcomes Mike Tyson GBank Financial Holdings Inc. is excited to announce a significant partnership with the legendary Mike Tyson. This strategic collaboration marks a new chapter for GBank, as Tyson steps in as both a strategic investor and promotional partner for the innovative company, BoltBetz. This new partnership aims to revolutionize...
Continue Reading